Letrozole
Back to searchMolecule Structure
Scientific Name
Letrozole
Description of the Drug
Letrozole is an aromatase inhibitor used to treat breast cancer in postmenopausal women.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01006
http://www.drugbank.ca/drugs/DB01006
Brand Name(s)
Femara, Letrozole
Company Owner(s)
Mylan Pharmaceuticals Inc, Novartis Pharmaceuticals Corp, Jiangsu Hengrui Pharmaceuticals Co Ltd, Impax Laboratories Inc, Fresenius Kabi Usa Llc, Indicus Pharma Llc, Accord Healthcare Inc, Synthon Pharmaceuticals Inc, Eugia Pharma Specialities Ltd, Dr Reddys Laboratories Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Cytochrome P450 19A1 | SINGLE PROTEIN | INHIBITOR | CHEMBL1978 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4331 | |
| PharmGKB | PA450196 | |
| Human Metabolome Database | HMDB0015141 | |
| DrugBank | DB01006 | |
| PubChem: Thomson Pharma | 14799856 | |
| PubChem | 3902 | |
| LINCS | LSM-3980 | |
| Nikkaji | J390.644B | |
| BindingDB | 13061 | |
| EPA CompTox Dashboard | DTXSID4023202 | |
| DrugCentral | 1556 | |
| Brenda | 18195 | |
| ChemicalBook | CB9286355 | |
| Guide to Pharmacology | 5209 | |
| rxnorm | LETROZOLE | FEMARA |
| PubChem: Drugs of the Future | 12014531 | |
| KEGG Ligand | C08163 | |
| ChEBI | 6413 | |
| ZINC | ZINC000003778874 |
